Don't know if this stock is going up due to IBB. Perhaps JMP presentation?
Continuation should continue into the 4s with ease. This has been way too low for way too long
NVIV will be bought right after FDA approval news. my guess is they will seek $15-20 range. price moves up to 10 before end of the year
only up 5% so far today ...I am a little disappointed
NEWS---Our CEO did a good job on the presentation today. Went through it at the right speed, no stammering or repeats, sounded confident, positive and motivated. Even with the same old slightly modified slide show he stayed on point and clear. I'm guessing he must have been rested and practiced. This was the best of all the show and tell sessions I have witnessed. Good Job Mark.
Congratulations to Allegheny Hospital for your support of medical history and being an ACTIVE participant in the INSPIRE study. For the last 2 weeks we've featured what appears to be "slackers" in the study. Population centers higher than most, who are elisted, yet have produced nothing in terms of new patients. Your participation is greatly appreciated, and illustrates your committment toward birthing a new SOC for these kinds of injuries. That alone offers more hope to the injured than anything else that has broached this realm of medical care. Congrats to the Allegheny team, the patient, and also to Invivo for getting to 16/20. Only four more to go to complete INSPIRE and then it is on to pure evaluation of the six month intervals for these patients and subbition of the data, already very compelling toward justifying approval.
For a lift go to Jesi's FB page. She is standing, happy and looking very strong. She says she is improving daily. Her implant was 2 years ago and she he was very badly injured.
I believe I've asked the following question before: anyone have an idea of why invivo hasn't updated Jesi's progress?
My guess is this is a very well funded short squeeze and it's making them squeal....
FINALLY A NEW PATIENT
Hey, no good reason why this stock is not above $8, much less $6, much less a measly $4, which it was stuck at very recently and was still undervalued. Can we at least get back to $4 with just 4 patients left to enroll?
Something is cooking. Possibly good news on the way
IMO nobody should be selling shares of NVIV today.
Approval is likely within a year which would mean this stock is going significantly higher $7+
Investor Presentation was updated.
this might squeeze to $4 by the close
NEW PATIENT!! Good News... Maybe more news today in the conference, Go Longs👍
a lot of negativity but the stock has bottomed and has been steadily moving up. I still see it as undervalued with file for approval on track for next year some time. I am glad I did not overpay for NVIV -and understand the view of unhappy shareholders who bought at inopportune time ..been in plenty of those situations....glta
When I see a pejorative remark intended to incite or belittle I go to the three dots in the corner and press mute for the individual. Remarks by that individual are blocked from my view.